Price
Target price
€0.48
€0.48
-2.450%
-0.012
-2.450%
-
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Beximco Pharmaceuticals Ltd. GDR Stock
A loss of -2.450% shows a downward development for Beximco Pharmaceuticals Ltd. GDR.
Pros and Cons of Beximco Pharmaceuticals Ltd. GDR in the next few years
Pros
?
S********** s********
?
B****
?
C******** o* t** e**********
Cons
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Beximco Pharmaceuticals Ltd. GDR vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Beximco Pharmaceuticals Ltd. GDR | -2.450% | -4.400% | -4.400% | 78.358% | 14.904% | -37.516% | -18.983% |
| SELLAS Life Sciences Group Inc | 9.440% | 12.662% | 2.756% | 38.584% | 66.419% | -23.721% | -28.753% |
| Eledon Pharmaceuticals Inc. | 3.740% | 7.767% | 3.738% | 0.000% | -45.588% | -20.144% | -84.486% |
| Check Cap Ltd | 1.000% | 9.189% | 254.386% | 54.198% | 94.231% | 601.876% | 577.852% |
News
Why Atai Life Sciences Stock Crushed It on Tuesday
Atai Life Sciences (NASDAQ: ATAI), an ambitious biotech that targets mental health disorders, was a hot item among equity investors Tuesday. The company saw its share price rise by just under 15%
